Zydus receives final approval from the USFDA for Efinaconazole Topical Solution
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Mittal will be driving expansion of the provider network across India
She joins Enveda from Gilead Sciences
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Plant is part of the company's CAD $30 million capital investment in the site
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Subscribe To Our Newsletter & Stay Updated